Femhealth Ventures Management LLC

Institutional venture firmSEC venture capital fund adviserfemhealthventures.com

FemHealth Ventures is a venture capital firm that seeks to invest in women

In the firm's own words, from its website.

Reported fund assets
$102M
sum of its funds' Form ADV filings, last 30 months
New companies, 12 mo
1
Investment team
3
Latest vintage
2024
Contact decision makers
More
Ask DFX about thisView relationshipsFind contactsInvestments (21)Team (5)Funds
As of · the latest observation of this organization; filed figures are as of its latest Form ADV

2 additional team members, 22 additional co-investors and affiliates, 18 additional investments, funds and LPs, 8 verified contacts (5 professional url, 1 general firm email, 1 published business email, 1 firm phone)

Every relationship, signal and contact on this record, with the source on each.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

What matters now

  1. 1 company
    new in 12 months

    1 new company in the last 12 months.

    A firm writing cheques this quarter is one a founder can pitch now.

    Factfunding announcements, Form D, the firm's portfolio pageFor Founders, co-investorsInvestments →
  2. 1 company
    portfolio raising

    One portfolio company has new financing on record in 6 months without this firm named on the round; the latest on 8 May 2026 ($50.1M sold on Form D).

    A portfolio company raising again is a follow-on decision for the firm and a co-investment opening for others.

    FactSEC Form D filingsFor Co-investors, LPs, lendersInvestments →
  3. 2 deals
    with Ascension Ventures

    Invests most often alongside Ascension Ventures (2 shared deals) and Evidity Capital (2 shared deals).

    pair last observed on record 17 Sep 2026, not a deal date · The firms it syndicates with are the likeliest to see the same deals and to fill out its rounds.

    Measuredshared rounds and portfolio companies on recordFor Founders building a round, co-investorsCo-investors →

People to know

View all people
  • Katherine Kalin
    Former McKinsey Partner & Pharma Exec
    Why: Partner: part of the investment decision
    Profile
  • Maneesha Ghiya
    Manager
    Why: Named with investment responsibility
    Profile

Relationship network

52 connected entities1 observed roundrounds 2026

From financing rounds and every investor named in them, Form ADV and Form D filings, the firm's funds and team, and disclosed LP commitments in the venture capital graph. A round's amount is the size of the round, not money that moved between two investors.

Some relationships on this record are counted rather than named here. They open with the full profile.

Click any name or line for the rounds and sources behind it. Line weight is rounds together; dashed lines are inferred.

Reading the network
  • Sponsor
  • Company
  • Fund or vehicle
  • Person

Co-investors are read from the rounds: three or more shared rounds is a strong observed relationship, two a repeat co-investor, one a single round. Funds and people are structural. Nothing is scored that a reader cannot check.

Darker lines were active in the last 24 months or are current; lighter lines are older or undated.

How am I connected?

Name your firm, a company or a person, and DFX finds the published routes to Femhealth Ventures Management LLC: a shared portfolio company or board, a prior employer, a co-investor, a shared LP or service provider. Every step is a filed or published record with its source; none is a guess about who knows whom.

See how you connect to Femhealth Ventures Management LLC

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

Investing

21 companies on record, 1 new in 12 months
Investments on record
21 companies, 0 partner-attributed
CompanyRoundRolePartnerRound sizeThis investorDateSource
10Beauty, Inc.portfolio listingunknownunknownunknownunknownOct 1, 2026Fact Firm website
Alyssum Therapeuticsportfolio listingunknownunknownunknownunknownOct 1, 2026Fact Firm website
AOA DX Inc.portfolio listingunknownunknownunknownunknownOct 1, 2026Fact Firm website
Stated thesis versus observed behaviour
22 observed deals
Stated (the firm’s website)
Sectors
healthcare
Stages
not stated or not yet read
Geography
global
Check size
not stated; DFX does not estimate checks from round sizes
Self-described
venture capital
Observed (from deals on record)
Stage at participation
series d plus 100%
Stage at first entry
series d plus 100%
Industries, each company once
Healthcare services (4)Life sciences (4)
lead rate 0%follow-on rate 0%new companies, 12 months 1

Team

5 current, 0 departed
Decision makers
who to call first, and why; then everyone else by function
  • Katherine Kalin · Former McKinsey Partner & Pharma Exec
    Why this person: Partner: part of the investment decision; Named with investment responsibility
    LinkedIn or profile link on file (firm website), confirmed 2026-10-01, confidence 90%
  • Maneesha Ghiya · Manager
    Why this person: Named with investment responsibility
    LinkedIn or profile link on file (firm website), confirmed 2026-10-01, confidence 90%
Who else at this firm · 1 person, grouped by function
Also on record (1)
  • Susanne Seripiero · Executive Administrator
    Why this person:
    LinkedIn or profile link on file (firm website), confirmed 2026-10-01, confidence 90%

Ranked by the role the firm or its filing states, a route on file and deals led. Every reason is read from the record, never inferred. 3 with a route on file. Routes are published by the person or the firm (their bio, the team page or a filing) and are revealed on a plan; data bought from a provider is never shown, and a route printed at a firm the person has since left is held back.

Investment team
5 current, 0 departed
Contacts
1 general firm email, 1 published business email, 1 firm phone, 5 professional url

1 general firm email, 1 published business email, 1 firm phone, 5 professional url on record, each with its source. Values open with the complete profile.

Funds and LPs

2 vehicles, 0 LPs disclosed
Funds and vehicles
2 reported
VehicleTypeVintageLifecycleReported GAVOwnersForm D soldLatest Form D
FemHealth Ventures Fund II LPFund2024 form d first saleFundraising$65.0M
Feb 27, 2026
94$39.9MSep 17, 2025
Femhealth Ventures Fund I LPFund2021 form d first saleMature$37.4M
Feb 27, 2026
74$11.9MOct 4, 2022
Limited partners
0 LPs, 0 disclosed commitments
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Known LPs and allocators
0 relationships across the firm's funds, from public pensions and the allocator graph
No allocator names this firm or its funds in a public disclosure DFX holds.

Relationships across DFX

25 co-investors
Co-investors
25 counted from shared deals, for the whole firm

Evidence and history

4 dated events, 55 observations from 3 sources
Timeline
4 dated events
  1. seen on or beforeSep 23, 2026
    Femhealth Ventures Management LLC: MICRO_VC -> INSTITUTIONAL_VC (venture manager, reported GAV $102M across 2 vehicles)
    Classification changedClassificationInferenceno URL
  2. Feb 27, 2026
    Femhealth Ventures Fund II LP first reported on Form ADV by Femhealth Ventures Management LLC (Venture Capital Fund), GAV $65,000,000
    Fund first reported on Form ADVFundsInferenceFemHealth Ventures Fund II LPForm ADV
  3. Jun 26, 2023
    Femhealth Ventures Management LLC first filed Form ADV (ERA, venture capital fund adviser exemption)
    First SEC adviser filingOrganizationFactForm ADV
  4. Jun 26, 2023
    Femhealth Ventures Fund I LP first reported on Form ADV by Femhealth Ventures Management LLC (Venture Capital Fund), GAV $30,172,888
    Fund first reported on Form ADVFundsFactFemhealth Ventures Fund I LPForm ADV
Identity and regulatory footprint
Address, phone, Form ADV filing and ownersForm ADV filed Feb 27, 2026 · 2 private fundsShow
Headquarters
unknown
Office address
unknown
Business phone
unknownadviserinfo.sec.gov
Website
femhealthventures.com
SEC adviser type
Exempt reporting adviseradviserinfo.sec.gov
SEC exemption claimed
Venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
Latest Form ADV
Feb 27, 2026
Private funds reported
2 (2 venture capital funds)adviserinfo.sec.gov
Private fund gross assets, adviser total
$102Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
Classification history
Every classification this record has carried3 on recordShow
  1. Sep 23, 2026
    Institutional venture firm (confirmed, 95%)
    Venture manager, reported GAV $102M across 2 vehicles
  2. Sep 12, 2026
    Micro VC (confirmed, 95%)
    Venture manager, reported GAV $32.0M across 2 vehicles
  3. Sep 12, 2026
    Micro VC (confirmed, 95%)
    Venture manager, reported GAV $32.0M across 1 vehicle
Evidence
63 observations from 3 sources
Every observation behind this profile, with its source, date and class
FactValueEffectiveClassSource
Why admittedVC exemption, VC funds reportedFeb 27, 2026FactForm ADV
SEC exemption claimedVenture capital fund adviserFeb 27, 2026FactForm ADV
SEC exemption claimedVenture capital fund adviserMar 20, 2024FactForm ADV
SEC adviser typeExempt reporting adviserFeb 27, 2026FactForm ADV
SEC adviser typeExempt reporting adviserFeb 27, 2026FactForm ADV
SEC adviser typeExempt reporting adviserMar 20, 2024FactForm ADV
First Form ADV filing2023-06-26Feb 27, 2026FactForm ADV
First Form ADV filing2023-06-26Mar 20, 2024FactForm ADV
Adv history loadedadv-hist-1+panel:2026-09-29Sep 30, 2026FactForm ADV
Adv history loadedadv-hist-1+panel:2026-09-25Sep 26, 2026FactForm ADV
Adv history loadedadv-hist-1+panel:2026-09-23Sep 24, 2026FactForm ADV
Adv history loadedadv-hist-1+panel:2026-09-21Sep 23, 2026FactForm ADV
Adv history loadedadv-hist-1+panel:2026-09-22Sep 23, 2026FactForm ADV
Adv history loadedadv-hist-1Sep 12, 2026FactForm ADV
Latest Form ADV filing2026-02-27Feb 27, 2026FactForm ADV
Latest Form ADV filing2026-02-27Feb 27, 2026FactForm ADV
Latest Form ADV filing2024-03-20Mar 20, 2024FactForm ADV
SEC statusERA - ActiveFeb 27, 2026FactForm ADV
SEC status effective2023-06-26Feb 27, 2026FactForm ADV
Venture share of reported funds1Feb 27, 2026FactForm ADV
Venture share of reported funds1Mar 20, 2024FactForm ADV
Business phoneFeb 27, 2026FactForm ADV
Business phoneMar 20, 2024FactForm ADV
Contact page urlOct 1, 2026Factno URL
Contact page urlSep 16, 2026Factno URL
DescriptionOct 1, 2026Factno URL
DescriptionSep 16, 2026Factno URL
DescriptionSep 13, 2026Factno URL
Self-described typeVenture capital
“Venture Capital”
Oct 1, 2026Factno URL
Self-described typeVenture capital
“Venture Capital”
Sep 16, 2026Factno URL
Self-described typeVenture capital
“Venture Capital”
Sep 13, 2026Factno URL
Legal formLimited Liability CompanyFeb 27, 2026FactForm ADV
Legal formLimited Liability CompanyMar 20, 2024FactForm ADV
Portfolio pageOct 1, 2026Factno URL
Portfolio pageSep 16, 2026Factno URL
Portfolio pageSep 13, 2026Factno URL
Private funds reported2Feb 27, 2026FactForm ADV
Private funds reported2Feb 27, 2026FactForm ADV
Private funds reported1Mar 20, 2024FactForm ADV
Private fund gross assets (reported)$102MFeb 27, 2026FactForm ADV
Private fund gross assets (reported)$102MFeb 27, 2026FactForm ADV
Private fund gross assets (reported)$32.0MMar 20, 2024FactForm ADV
Schedule a diffsadiff-1Sep 27, 2026FactForm ADV
Stated geographyglobal
“geography words on the home page”
Oct 1, 2026Factno URL
Stated geographyglobal
“geography words on the home page”
Sep 16, 2026Factno URL
Stated geographyglobal
“geography words on the home page”
Sep 13, 2026Factno URL
Stated sectorshealthcare
“sector words on the home page”
Oct 1, 2026Factno URL
Stated sectorshealthcare
“sector words on the home page”
Sep 16, 2026Factno URL
Stated sectorshealthcare
“sector words on the home page”
Sep 13, 2026Factno URL
Team pageOct 1, 2026Factno URL
Team pageSep 16, 2026Factno URL
Team pageSep 13, 2026Factno URL
Venture funds reported2Feb 27, 2026FactForm ADV
Venture funds reported2Feb 27, 2026FactForm ADV
Venture funds reported1Mar 20, 2024FactForm ADV
WebsiteFeb 27, 2026FactForm ADV
WebsiteMar 20, 2024FactForm ADV
Site titleOct 1, 2026Factno URL
Site titleSep 16, 2026Factno URL
Site titleSep 13, 2026Factno URL
How this is scored
Scores, classification basis and filing advisersInstitutional venture firm, confirmedShow
Importance
34
moderate
Active deployment
29
moderate
Emerging
59
elevated
Freshness
100
high
Institutional venture firmSEC exempt reporting adviser

Venture manager, reported GAV $102M across 2 vehicles

The inputs behind each score
importance
gav: $0 · funds: 0.17 · people: 0.16 · investments: 0.5 · co investors: 0.56
active deployment
investments 12m: 0.13 · fund raising 18m: 0 · people joined 12m: 0 · vintage within 3y: 1 · latest investment at: 2026-06-09
emerging manager
fund count: 2 · reported gav: $102M · first adv filing: 2023-06-26 · years since first filing: 3.3

Fits, record history and connections

scored matches for this investor, every identity change, every edge

Fits

2 scored matches, best firstas of
  • score 34.3confidence 90%
    Why: stage fit; activity; cap table
  • score 29.3confidence 80%
    Why: stage fit; activity

Scored by DFX match engines from the record's observed portfolio, stage, geography and recent activity. A fit is a reason to look, not a mandate; the blockers say what the model could not confirm. Names and the evidence sentences show with the names on this page.

Record history

1 identity change, 2 dated events on the change ledger, latest event first
  • Organization classification changed
    2026-09-23
  • Merged in
    2026-09-14
  • Adviser's first ADV filing
    2023-06-26source on record

The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.